{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:18:48Z","timestamp":1781522328869,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T00:00:00Z","timestamp":1392422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40618-014-0057-x","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T16:11:11Z","timestamp":1392653471000},"page":"533-539","source":"Crossref","is-referenced-by-count":8,"title":["Lipodystrophy syndrome in HIV treatment-multiexperienced patients: implication of resistin"],"prefix":"10.1007","volume":"37","author":[{"given":"V.","family":"Arama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. I.","family":"Munteanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Streinu Cercel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. A.","family":"Ion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mihailescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tiliscan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S.","family":"Arama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,15]]},"reference":[{"key":"57_CR1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkn251","volume":"62","author":"JE Mallewa","year":"2008","unstructured":"Mallewa JE, Wilkins E, Vilar J et al (2008) HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. J Antimicrob Chemother 62:648\u2013660","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"57_CR2","first-page":"7","volume":"44","author":"O Omolayo","year":"2008","unstructured":"Omolayo O, Sealy PL (2008) HIV lipodystrophy syndrome. Hosp Physician 44(5):7\u201314","journal-title":"Hosp Physician"},{"issue":"4","key":"57_CR3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.11599\/germs.2012.1024","volume":"2","author":"DM Jianu","year":"2012","unstructured":"Jianu DM (2012) A new scientific era in biomedicine\u2014regenerative surgery based on lipotransplant. New therapeutic horizons for HIV-positive patients. GERMS 2(4):135\u2013136","journal-title":"GERMS"},{"key":"57_CR4","unstructured":"Georg Behrens, Reinhold E (2011) Schmidt. Lipodystrophy syndrome. Chapter 8 HIV In: Christian Hoffmann and J\u00fcrgen K. Rockstroh (ed) Medizin Fokus Verlag, Berlin"},{"issue":"2","key":"57_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11154-013-9247-7","volume":"14","author":"O Galescu","year":"2013","unstructured":"Galescu O, Bhangoo A, Ten A (2013) Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV\/AIDS. Rev Endocr Metab Disord 14(2):133\u2013140","journal-title":"Rev Endocr Metab Disord"},{"key":"57_CR6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(03)12656-6","volume":"361","author":"A Carr","year":"2003","unstructured":"Carr A, Emery S, Law M et al (2003) An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet 361:726\u2013735","journal-title":"Lancet"},{"key":"57_CR7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/157016206775197664","volume":"4","author":"G Barbaro","year":"2006","unstructured":"Barbaro G (2006) Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection. Curr HIV Res 4:79\u201385","journal-title":"Curr HIV Res"},{"key":"57_CR8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/QAD.0b013e3280adc91e","volume":"21","author":"LL Sweeney","year":"2007","unstructured":"Sweeney LL, Brennan AM, Mantzoros CS (2007) The role of adipokines in relation to HIV lipodystrophy. AIDS 21:895\u2013904","journal-title":"AIDS"},{"key":"57_CR9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkm475","volume":"61","author":"K Samaras","year":"2008","unstructured":"Samaras K (2008) Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection. J Antimicrob Chemother 61:238\u2013245","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"57_CR10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/QAI.0b013e318213312c","volume":"57","author":"X Escote","year":"2011","unstructured":"Escote X, Miranda M, Veloso S et al (2011) Lipodystrophy and insulin resistance in combination Antiretroviral treated HIV-1\u2013infected patients: implication of resistin. J Acquir Immune Defic Syndr 57(1):16\u201323","journal-title":"J Acquir Immune Defic Syndr"},{"key":"57_CR11","volume-title":"Obesity: preventing and managing the global epidemic. Technical Report Series No. 894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic. Technical Report Series No. 894. WHO, Geneva"},{"key":"57_CR12","unstructured":"The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation 2006. http:\/\/www.idf.org\/webdata\/docs\/IDF_Meta_def_final.pdf . Accessed Sept 2012"},{"key":"57_CR13","unstructured":"HIV\/AIDS Monitoring and Evaluation Department of the National AIDS Comission for Romania\u2014 http:\/\/www.cnlas.ro\/images\/doc\/epidemiology_sept2011.pdf . Accessed Sept 2011"},{"key":"57_CR14","unstructured":"Country Progress Report on AIDS January 2010\u2013December 2011. http:\/\/www.unaids.org\/en\/dataanalysis\/monitoringcountryprogress\/progressreports\/2012countries\/ce_RO_Narrative_Report.pdf . Accessed Sept 2012"},{"issue":"2","key":"57_CR15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.meegid.2010.07.002","volume":"11","author":"S Paraschiv","year":"2011","unstructured":"Paraschiv S, Foley B, Otelea D (2011) Diversity of HIV-1 subtype C strains isolated in Romania. Infection, genetics and evolution. J Mol Epidemiol Evol Genet Infect Dis 11(2):270\u2013275","journal-title":"J Mol Epidemiol Evol Genet Infect Dis"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6823-13-4","volume":"13","author":"V Arama","year":"2013","unstructured":"Arama V, Tiliscan C, Streinu-Cercel A et al (2013) Insulin resistance and adipokines serum levels in a Caucasian cohort of HIV-positive patients undergoing antiretroviral therapy: a cross sectional study. BMC Endocr Disord 13:4","journal-title":"BMC Endocr Disord"},{"issue":"11","key":"57_CR17","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/jc.2002-021808","volume":"88","author":"M Degawa-Yamauchi","year":"2003","unstructured":"Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 88(11):5452\u20135455","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"57_CR18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1210\/jc.2003-031121","volume":"89","author":"BS Youn","year":"2004","unstructured":"Youn BS, Yu KY, Park HJE et al (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89(1):150\u2013156","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"57_CR19","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1210\/jc.2005-0742","volume":"90","author":"D Barb","year":"2005","unstructured":"Barb D, Wadhwa SG, Kratzsch J et al (2005) Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome. J Clin Endocrinol Metab 90(9):5324\u20135328","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"57_CR20","first-page":"193","volume":"28","author":"MI Spagnuolo","year":"2010","unstructured":"Spagnuolo MI, Caiazzo MA, Franzese A et al (2010) Side effects of highly active antiretroviral therapy in children with AIDS: phase angle alpha, serum resistin levels, and ultrasound as predictors of malnutrition. Nutr Ther Metab 28(4):193\u2013197","journal-title":"Nutr Ther Metab"},{"key":"57_CR21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","volume":"7","author":"CG Fiorenza","year":"2011","unstructured":"Fiorenza CG, Chou SH, Mantzoros CS (2011) Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 7:137\u2013150","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"57_CR22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3844\/ajidsp.2006.141.152","volume":"2","author":"S Tsiodras","year":"2006","unstructured":"Tsiodras S, Mantzoros C (2006) Leptin and adiponectin in the HIV associated metabolic syndrome: physiologic and therapeutic implications. Am J Infect Dis 2(3):141\u2013152","journal-title":"Am J Infect Dis"},{"issue":"2","key":"57_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","volume":"152","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of Leptine in human physiology: emerging clinical applications. Ann Intern Med 152(2):93\u2013100","journal-title":"Ann Intern Med"},{"key":"57_CR24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350300800102","volume":"8","author":"L Kosmiski","year":"2003","unstructured":"Kosmiski L, Kuritzkes D, Lichtenstein K, Eckel R (2003) Adipocyte-derived hormone levels in HIV lipodystrophy. Antivir Ther 8:9\u201315","journal-title":"Antivir Ther"},{"key":"57_CR25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1468-1293.2010.00837.x","volume":"12","author":"S Resino","year":"2011","unstructured":"Resino S, Micheloud D, Lorente R, Bellon JM, Navarro ML, Munoz-Fernandez MA (2011) Adipokine profiles and lipodystrophy in HIV-infected children during the first 4\u00a0years on highly active antiretroviral therapy. HIV Med 12:54\u201360","journal-title":"HIV Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0057-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0057-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:25:56Z","timestamp":1688999156000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0057-x","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,15]]}}}